miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers
Yulei Wei, Li Hong, Quanxin Qu
Topics & Concepts
KLF4CD44TamoxifenSOX2Cancer researchCancer stem cellEstrogen receptorMedicineStem cellCancerBreast cancerInternal medicineOncologyCellBiologyTranscription factorCell biologyBiochemistryGeneGeneticsKruppel-like factors researchGenetic Syndromes and ImprintingMicroRNA in disease regulation